Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Two Eltrombopag Olamine 25 mg Film-coated Tablet Formulations Under Fasting Conditions
TCTR20241231006Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of eltrombopag (2 arms), sponsored by Dr. Reddy's Laboratories. Started Feb 2025; status: completed.
02
Drugs
eltrombopag
Beyond the preview
Go deeper on TCTR20241231006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241231006.